Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT01160211 |
Title | A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase III |
Variant Requirements | Yes |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS |